Skip to main content
Log in

Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Due to the well-known intradialytic haemoglobin (Hb) change, it has been suggested that true functional Hb differs from pre-dialysis Hb. However, mechanisms of this change are not understood properly. We aimed at studying the role of plasma volume variation.

Methods

This is a multicentre study with two consecutive phases. First, true functional Hb was predicted by Krisper’s formula that estimates time-averaged haemoglobin concentration (TAC-Hb) and by the average (Avg-Hb) of Pre-Hb and Post-Hb (n = 346). Erythropoiesis-stimulating agent (ESA) doses were estimated according to the FDA instructions. Second, we investigated the correlations between Hb changes (ΔHb), body weight loss (ΔBW) and relative plasma volume changes (%ΔPV) in subjects with a weight gain higher than 1 kg (n = 208).

Results

First: Avg-Hb and TAC-Hb were similar to each other and higher than midweek Pre-Hb (p < 0. 002). Odds of having an Hb change >1 g/dL were 0.415. Odds were similar in both women and men [odds ratio (OR) 0.923; 95 % confidence interval (CI) 0.591–1.441]. If ESA doses were estimated by TAC-Hb or Avg-Hb instead of Pre-Hb, they should be lower in 40 % of the 346 patients. Second: Mean %ΔPV was −12.1 % (95 % CI −10.72/−13.48), and mean ΔHb was 1.1 g/dL (95 % CI 0.97/1.25). Correlation between ΔHb and %ΔPV was −0.92 (r 2 0.84) whereas that of ΔHb/ΔBW was just −0.45 (r 2 0.21; p < 0.000). Prevalence of ΔHb >1 g/dL was independent of ΔBW from 1.4 to 6.3 kg. By contrast, prevalence of ΔHb >1 g/dL in %ΔPV quartiles was clearly linear: 0, 52, 90 and 100 %, respectively.

Conclusions

Plasma volume variations play a major role in intradialytic Hb change. True functional Hb should be estimated in all patients with a weight gain higher than 1 kg.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetesand chronic kidney disease. N Engl J Med 361:2019–2032

    Article  PubMed  Google Scholar 

  2. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM et al (1998) The effects of normal as compared with low hematocrit values inpatients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590

    Article  CAS  PubMed  Google Scholar 

  3. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M et al (2006) Correction of anaemia with epoetin alpha in chronic kidney disease. N Engl J Med 355:2085–2098

    Article  CAS  PubMed  Google Scholar 

  4. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anaemia. N Engl J Med 355:2071–2084

    Article  CAS  PubMed  Google Scholar 

  5. Unger EF, Thompson AM, Blank MJ, Temple R (2010) Erythropoiesis-stimulating agents, time for a reevaluation. N Engl J Med 362(3):189–192

    Article  CAS  PubMed  Google Scholar 

  6. Vlassopoulos D, Sonikian M, Dardioti V, Hadjiconstaninou V (1999) Target haematocrit during erythropoietin treatment in dialysis patients. Which value is ‘true-functional haematocrit’? Nephrol Dial Transplant 14:1340

    Article  CAS  PubMed  Google Scholar 

  7. Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD (2003) Prediction of time-averaged concentration of haemoglobin in haemodialysis patients. Nephrol Dial Transpl 18:2082–2087

    Article  CAS  Google Scholar 

  8. Castillo et al (2012) Should we adjust erythropoiesis stimulating agent dosage to postdialysis hemoglobin levels? A pilot study. BMC Nephrol 13:60

    Article  Google Scholar 

  9. Korzets A, Ori Y, Zevin D, Gafter U (2002) Posthemodialysis hemoglobin levels: overdue or not? Am J Kidney Dis 40(4):873

    Article  PubMed  Google Scholar 

  10. Bellizzi V, Minutolo R, Terracciano V et al (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549–555

    Article  CAS  PubMed  Google Scholar 

  11. Geller A, DeVita M, Marku-Podvorica J, Rosenstock J, Panagopoulos G, Michelis M. Increase in post-dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration. Dialysis & Transplantation 2010 (February: 1–4)

  12. Minutolo R, De Nicola L, Bellizzi V (2003) Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients. Nephrol Dial Transpl 18:2606–2612

    Article  CAS  Google Scholar 

  13. Daugirdas JT, Tattersall J (2010) Effect of treatment spacing and frequency on three measures of equivalent clearance, including standard Kt/V. Nephrol Dial Transpl 25(2):558–561

    Article  CAS  Google Scholar 

  14. PROCRIT (epoetin alpha) [Nephrology prescribing information]. Amgen: Th Oaks, 2011 (http://www.procrit.com/sites/default/files/pdf/ProcritBooklet.pdf)

  15. van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 32(5):712–713

    PubMed  Google Scholar 

  16. Koomans H, Geers A (1984) Dorhout Mees E. Plasma volume recovery after ultrafiltration in patients with chronic renal failure. Kidney Int 26:848–854

    Article  CAS  PubMed  Google Scholar 

  17. Bland J, Altman G (2003) Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22:85–93

    Article  CAS  PubMed  Google Scholar 

  18. Sedgwick P (2012) What are odds? BMJ 344:e2853

    Article  Google Scholar 

  19. Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G, Maffei C, Maiorca R (2004) Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. Nephrol Dial Transplant 19:185–189

    Article  PubMed  Google Scholar 

  20. Movilli E, Pertica N, Camerini C et al (2002) Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. Am J Kidney Dis 39:850–853

    Article  CAS  PubMed  Google Scholar 

  21. Siga E, Aiziczon D, Diaz G (2011) Optimizacion del tratamiento con hierro endovenoso en hemodiálisis. Estudio Clinico prospectivo a largo plazo. Medicina (Bs. As) 71:9–14

    CAS  Google Scholar 

Download references

Conflict of interest

All authors state that they have no conflict of interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Esteban Siga.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siga, E., Fernandez, M., Galarza, M. et al. Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study. Int Urol Nephrol 46, 2379–2384 (2014). https://doi.org/10.1007/s11255-014-0774-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0774-2

Keywords

Navigation